Pharmacologic management of diabetic nephropathy
- 1 November 2002
- journal article
- review article
- Published by Elsevier in Clinical Therapeutics
- Vol. 24 (11) , 1741-1756
- https://doi.org/10.1016/s0149-2918(02)80076-5
Abstract
No abstract availableKeywords
This publication has 46 references indexed in Scilit:
- Nephropathy in Patients with Type 2 Diabetes MellitusNew England Journal of Medicine, 1999
- The sixth report of the Joint National Committee on prevention, detection, evaluation, and treatment of high blood pressureArchives of internal medicine (1960), 1997
- Effect of deletion polymorphism of angiotensin converting enzyme gene on progression of diabetic nephropathy during inhibition of angiotensin converting enzyme: observational follow up studyBMJ, 1996
- Blood Pressure and End-Stage Renal Disease in MenNew England Journal of Medicine, 1996
- Nephropathy in Type 1 Diabetes: the Role of Genetic FactorsDiabetic Medicine, 1995
- Lipids and the kidneyKidney International, 1994
- Smoking Is Associated With Progression of Diabetic NephropathyDiabetes Care, 1994
- The link between hyperglycaemia and diabetic nephropathyDiabetologia, 1992
- Efficacy of captopril in postponing nephropathy in normotensive insulin dependent diabetic patients with microalbuminuria.BMJ, 1991
- Disparities in Incidence of Diabetic End-Stage Renal Disease According to Race and Type of DiabetesNew England Journal of Medicine, 1989